Intratumoral heterogeneity and consequences for targeted therapies
نویسندگان
چکیده
منابع مشابه
Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies
Strategies to enhance the already established doublet chemotherapy regimen for lung cancer have been investigated for more than 20 years. Initially, the concept was to administer chemotherapy drugs locally to the tumor site for efficient diffusion through passive transport within the tumor. Recent advances have enhanced the diffusion of pharmaceuticals through active transport by using pharmace...
متن کاملGenetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapies
Cholangiocarcinoma (CC) encompasses a group of related but distinct malignancies whose lack of a stereotyped genetic signature makes challenging the identification of genomic landscape and the development of effective targeted therapies. Accumulated evidences strongly suggest that the remarkable genetic heterogeneity of CC may be the result of a complex interplay among different causative facto...
متن کاملIntratumoral functional heterogeneity and chemotherapy.
Intratumoral heterogeneity including genetic and nongenetic mechanisms refers to biological differences amongst malignant cells originated within the same tumor. Both, cell differentiation hierarchy and stochasticity in gene expression and signaling pathways may result in phenotypic differences of cancer cells. Since a tumor consists of cancer cell clones that display distinct behaviours, chang...
متن کاملIntratumoral heterogeneity of intrahepatic cholangiocarcinoma
No personalized therapy regimens could demonstrate a benefit in survival of intrahepatic cholangiocarcinoma (iCCA). Since genetic heterogeneity might influence single biopsy based targeted therapy or the outcome of clinical trials, aim of the present study was to investigate intratumoral heterogeneity of iCCA by whole exome sequencing. Therefore, samples from tumor center and tumor periphery of...
متن کاملIntratumor heterogeneity in hepatocellular carcinoma Running title: Implications for tumor classifications and targeted therapies
Financial support: This work was supported by the following grants: A grant from the TheilerHaag Stiftung, Zurich to AW and LF. Grants from the Krebsliga Schweiz (Oncosuisse), Promedica Stiftung, the „Julius Müller Stiftung“, and from the “Kurt and Senta Herrmann Stiftung”, Vaduz, Lichtenstein to AW and MH. MH is also supported by an ERC Starting grant “LiverCancerMechanism”, the Hofschneider f...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Bulletin du Cancer
سال: 2015
ISSN: 0007-4551
DOI: 10.1016/j.bulcan.2014.12.006